The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 26, 2019

Filed:

Sep. 01, 2017
Applicant:

Csir, Pretoria, ZA;

Inventors:

Jerolen Naidoo, Pretoria, ZA;

Samantha Barichievy, Gothenburg, SE;

Rethabile Khutlang, Johannesburg, ZA;

Musa M Mhlanga, Johannesburg, ZA;

Assignee:

CSIR, Pretoria, ZA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); C12N 15/113 (2010.01); A61K 38/12 (2006.01); A61K 31/436 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/454 (2006.01); A61K 31/475 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/501 (2006.01); A61K 31/5025 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/5377 (2006.01); A61K 31/675 (2006.01); A61K 31/713 (2006.01); A61K 33/24 (2019.01); C12Q 1/70 (2006.01); A61K 31/197 (2006.01); A61K 31/4709 (2006.01); A61K 31/58 (2006.01); A61K 31/7072 (2006.01); C12N 15/11 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); A61K 31/197 (2013.01); A61K 31/436 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/454 (2013.01); A61K 31/475 (2013.01); A61K 31/4709 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/5025 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/58 (2013.01); A61K 31/675 (2013.01); A61K 31/7072 (2013.01); A61K 31/713 (2013.01); A61K 33/24 (2013.01); A61K 38/12 (2013.01); C12N 15/111 (2013.01); C12N 15/1132 (2013.01); C12Q 1/703 (2013.01); C12N 2310/113 (2013.01); C12N 2310/141 (2013.01); C12N 2320/10 (2013.01); C12N 2320/11 (2013.01); C12N 2320/30 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/178 (2013.01);
Abstract

The present invention relates to methods for the identification of anti-HIV miRNAs and anti-HIV pharmaceutical compounds using high-throughput screening methods, comprising: transfecting reporter cells with a panel of miRNAs, infecting the reporter cells with HIV, screening the cells to identify miRNAs that modulate HIV infection and identifying the specific pathways, nucleic acids and/or polypeptides that are targeted by the miRNAs. The invention further provides for the identification and screening of anti-HIV pharmaceutical compounds having known activity against the specific pathways, nucleic acids and/or polypeptides that are targeted by the miRNAs for efficacy in the treatment of HIV. The invention also provides for the use of miRNA mimics, miRNA inhibitors and pharmaceutical compounds (including oncology drugs and kinase inhibitors) in the treatment and/or prevention of HIV infection.


Find Patent Forward Citations

Loading…